Insider Transactions in Q2 2022 at Vertex Pharmaceuticals Inc (VRTX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2022
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Payment of exercise price or tax liability
|
Direct |
1,344
-2.78%
|
$353,472
$263.09 P/Share
|
|
Apr 01
2022
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,582
-1.14%
|
$681,648
$264.56 P/Share
|
|
Apr 01
2022
|
Kristen Ambrose SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
137
-3.46%
|
$36,031
$263.09 P/Share
|